Nivolumab for Patients With High-Risk Oral LeukoplakiaGlenn J. Hanna, Sook‐Bin Woo, Anne O’Neill et al.|JAMA Oncology|2023Cited by 56
Dual Immune Checkpoint Inhibition in Patients With Aggressive Thyroid CarcinomaKartik Sehgal, Jochen H. Lorch, Θεοδώρα Παππά et al.|JAMA Oncology|2024Cited by 38